ImmunityBio, Inc. (IBRX)
NASDAQ·Healthcare·Biotechnology
$6.98
-4.32%
Mkt Cap $8.30B
Analyst Ratings
Buy
24
Hold
0
Sell
0
Price Target (5 analysts)
$13.50
Range $12.00 – $15.00
Implied Upside
+93.5%
Consensus $13.50 vs current $6.98
NASDAQ·Healthcare·Biotechnology
$6.98
-4.32%
Mkt Cap $8.30B
Buy
24
Hold
0
Sell
0
Price Target (5 analysts)
$13.50
Range $12.00 – $15.00
+93.5%
Consensus $13.50 vs current $6.98